Quarterly report · Q1
2150.TEDINET S100QR5M
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.5bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥715m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥838m | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥839m | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥716m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥839m | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥458m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥558m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥464m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥564m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥12.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥13.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥10.1bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥8.4bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥10.27 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.7 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.61 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥336m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥2.3bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥985m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥227m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥66m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥2.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥308m |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E05684-000Medical Digital Transformation Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥1.1bn |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥207m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥207m |
| jpcrp040300-q1r_E05684-000Medical Platform Businessreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥88m |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥2.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥2.2bn |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 327
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_SharesWithFullVotingRightsOtherMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式 | |
| Description issued shares voting rights | CurrentQuarterInstant_SharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)株式会社ケアネット | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都千代田区富士見一丁目８番19号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding inventories (text) | CurrentQuarterInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentQuarterInstant | Text · Plus | |
| Description of fact that quarterly statement of cash flows has not been prepared (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |